Managing Metastatic Prostate Cancer In Your Urological Oncology Practice
Novel therapies in castration-resistant prostate cancer
Publication
, Chapter
Lash, T; Bitting, RL
January 1, 2016
Duke Scholars
DOI
ISBN
9783319313399
Publication Date
January 1, 2016
Start / End Page
259 / 269
Citation
APA
Chicago
ICMJE
MLA
NLM
Lash, T., & Bitting, R. L. (2016). Novel therapies in castration-resistant prostate cancer. In Managing Metastatic Prostate Cancer In Your Urological Oncology Practice (pp. 259–269). https://doi.org/10.1007/978-3-319-31341-2_15
Lash, T., and R. L. Bitting. “Novel therapies in castration-resistant prostate cancer.” In Managing Metastatic Prostate Cancer In Your Urological Oncology Practice, 259–69, 2016. https://doi.org/10.1007/978-3-319-31341-2_15.
Lash T, Bitting RL. Novel therapies in castration-resistant prostate cancer. In: Managing Metastatic Prostate Cancer In Your Urological Oncology Practice. 2016. p. 259–69.
Lash, T., and R. L. Bitting. “Novel therapies in castration-resistant prostate cancer.” Managing Metastatic Prostate Cancer In Your Urological Oncology Practice, 2016, pp. 259–69. Scopus, doi:10.1007/978-3-319-31341-2_15.
Lash T, Bitting RL. Novel therapies in castration-resistant prostate cancer. Managing Metastatic Prostate Cancer In Your Urological Oncology Practice. 2016. p. 259–269.
DOI
ISBN
9783319313399
Publication Date
January 1, 2016
Start / End Page
259 / 269